SMO mutant olfactory groove meningiomas-the next in line for targeted therapy

Neuro Oncol. 2017 Mar 1;19(3):305-306. doi: 10.1093/neuonc/now302.

Authors

Christopher Alvarez-Breckenridge¹, Priscilla K Brastianos^{2

3}

Affiliations

¹ Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
² Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
³ Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

No abstract available

Publication types

Comment

MeSH terms

Humans
Meningeal Neoplasms / surgery*
Meningioma / surgery*
Neurosurgical Procedures
Smoothened Receptor

Substances

SMO protein, human
Smoothened Receptor